BF2/肽四聚体的构建及其在传染性支气管炎病毒特异性T细胞反应评价中的应用
|
摘要
MHCⅠ类分子/肽四聚体技术是1996年建立的一种检测特异性细胞毒性T淋巴细胞(cytotoxicT lymphocytes，CTLs)的方法，该方法已在人类及模式动物的相关领域得到较为广泛的研究和应用，然而在兽医学相关研究中只有近年来往猪和马上有了初步的研究，目前该项技术在禽类的研究尚属空白。
为了构建鸡的MHC/肽四聚体，本实验从SPF莱航鸡全血克隆了鸡MHCⅠ重链α(BF2)和β2微球蛋白(Chβ2m)全基因，经系统进化分析表明本实验所获得的BF2基因为B15单倍型。然后利用软件分析了其各自的信号肽序列及BF2的跨膜区，利用引物分别缺失了这两段基因的信号肽序列以及BF2的跨膜区，并在BF2基因的3’端融合了BirA底物肽(BSP)序列。将经改造的两段基因分别克隆至融合蛋白重组表达载体中，分别命名为pET-BF_2-BSP和pET-Chβ2m，并将其分别转化至大肠杆菌感受态BL21(DE3)中进行诱导表达，获得了包涵体表达的重组蛋白，表达产物溶解于8M脲中，经SDS-PAGE分析，结果表明所得融合目的蛋白分别约为38kD和15kD，Western-blot结果显示该重组蛋白均成功融合了6×His标签。为了获得大量的目的蛋白，优化了诱导剂浓度、起始诱导菌体浓度及诱导时间等表达条件。此外，建立了重组蛋白BF2-BSP和Chβ2m在变性状态下通过镍柱亲和层析纯化包涵体的方法，获得了高纯度的重组蛋白BF2-BSP和Chβ2m。
根据文献所报道，合成了鸡传染性支气管炎病毒(IBV)核蛋白N_(71-78)T细胞表位肽，将其与纯化后的重组蛋白BF2-BSP和Chβ2m在重折叠缓冲液中复性。复性后在快速蛋白液相色谱仪(FPLC)上分离出复性组装成功的BF2/肽单体复合物。将该单体复合物在体外进行生物素化，其产物再次采用FPLC通过分子筛分离出生物素化后的BF2/肽单体复合物；通过链霉亲和素迁移实验检测体外生物素化效率，然后将生物素化后的BF2/肽单体复合物与藻红蛋白(PE)标记的链霉亲和素按一定比例反应生成BF2/肽四聚体。
为了检测所制备BF2/肽四聚体的功能，采用10~(5.5)EID_(50)的IBV H52株接种一周龄SPF鸡，10d后采抗凝血用淋巴细胞分离液分离PBMC，调整细胞浓度后取1×10~6个细胞进行抗鸡CD8单抗和BF2/肽四聚体双色荧光染色，采用流式细胞术检测并分析染色结果，结果表明所制备的BF2/肽四聚体可用于检测IBV N蛋白特异性T淋巴细胞，检测一周龄SPF鸡接种H52后10d时针对N蛋白的特异性T细胞比率为3.65％。
为了探讨SPF鸡在感染IBV后体内抗体水平及针对N蛋白特异性的T淋巴细胞的动态变化，将125羽SPF鸡随机分为三组分别作为接种免疫组、攻毒对照组和空白对照组。采用IBV H52标准毒株对其通过滴鼻方式进行免疫，之后每3天剖杀5羽观察各脏器的病理学变化、检测血清抗体效价并采用BF2/肽四聚体评价其N蛋白特异性T细胞的比例；免疫15d时采用IBV M41对免疫组和攻毒对照组进行攻毒，同样检测上述指标。最后综合评价IBV在免疫及攻毒后血清抗体和
N蛋白特异性T细胞的动态变化趋势及两者之间的相互关系。检测结果表明H52滴鼻免疫后特异性T细胞免疫的产生早于血清抗体IgG的出现，攻毒结果显示在SPF鸡未产生坚强的体液免疫时仍能抵抗同型强毒的攻击，提示特异性T细胞在抵抗IBV早期感染免疫反应过程中可能起着重要作用。
The major histocompatibility complex classⅠ(MHC classⅠ) peptide tetramer is a sensitive tool to evaluate antigen-specific cytotoxic T lymphocytes(CTLs). However, no chicken MHC classⅠpeptide tetramer has been reported by now.
In order to construct the chicken MHC classⅠpeptide tetramer, genes of the chicken MHCⅠαchain(BF2*15) andβ2 microglobulin(Chβ2m) were amplified from the total RNA of peripheral blood monouclear cells(PBMCs) by RT-PCR and cloned into pMD18-T. Then the PCR products deleted the signal sequence at the 5' end of both the BF2 and Chβ2m genes and included the BirA substrate peptide(BSP) sequence at the 3' end of the BF2 gene were sub-cloned into the expression vector pET-28a(+) and named as pET-BF2-BSP and pET-Chβ2m. High levels of BF2-BSP and Chβ2m proteins were successfully expressed in E. coli strain BL21(DE3) transformed with the recombinant vectors pET-BF2-BSP and pET-Chβ2m. The recombinant target proteins were purified with a Ni~(2+)NTA column including His-Bind Resin, and then high-quality recombinant proteins were recovered.
BF2-BSP and Chβ2m were refolded with synthetic peptide originated from infectious bronchitis virus nucleoprotein(IBV N_(71-78)) in refolding buffer to generate the monomer of BF2/peptide complex. The folded product was then subjected to enzymatic biotinylation by BirA enzyme. After biotinylation the sample was run over a gel filtration column to purify the BF2/peptide fraction. The tetrameric complexes of biotinylated BF2/peptide were produced by mixing purified, biotinylated monomer with PE-labeled streptavidin at a molar ratio of 4:1.
In order to test the function of the prepared BF2/peptide tetramer, one-week SPF chicks were immunized with 10~(5.5)EID_(50) IBV H52 strain through intranasal inoculation. The PBMCs were isolated at 10 days post infection(d.p.i.) and used for flow cytometry staining. The CTLs response of IBV-infected chicks was evaluated with the prepared BF2/peptide tetramer and 3.65% CTLs frequency specific to IBV N was detected.
To discuss the kinetics of the antibody titer and the IBV N-specific T cell when the SPF chicks were infected with the IBV, 125 SPF chicks were divided into three groups at random, namely vaccinated group, challenge control group and negative control group. The SPF chicks from the vaccinated group were immunized with 10~(5.5)EID_(50) IBV H52 strain through intranasal inoculation. Five chicks were sacrificed every three days for pathogenesis observation, assessment of antibody titer and IBV N-specific T cell measured by prepared BF2/peptide tetramer. The chicks from vaccinated group and challenge control group were challenged with IBV M41 at the day 15 after vaccination. Also, the same assessments were taken on as described above. All the results were pooled together to investigate the interaction between the antibody titer and nucleoprotein-specific T cell after vaccination and challenge.
The results indicated that the CTL activity was shown to be effective during the initial elimination of virus in the chicks, later control of infection probably depends on antibody, especially the IgG response, which likely plays a important role in preventing recrudescence of infection.
为了构建鸡的MHC/肽四聚体，本实验从SPF莱航鸡全血克隆了鸡MHCⅠ重链α(BF2)和β2微球蛋白(Chβ2m)全基因，经系统进化分析表明本实验所获得的BF2基因为B15单倍型。然后利用软件分析了其各自的信号肽序列及BF2的跨膜区，利用引物分别缺失了这两段基因的信号肽序列以及BF2的跨膜区，并在BF2基因的3’端融合了BirA底物肽(BSP)序列。将经改造的两段基因分别克隆至融合蛋白重组表达载体中，分别命名为pET-BF_2-BSP和pET-Chβ2m，并将其分别转化至大肠杆菌感受态BL21(DE3)中进行诱导表达，获得了包涵体表达的重组蛋白，表达产物溶解于8M脲中，经SDS-PAGE分析，结果表明所得融合目的蛋白分别约为38kD和15kD，Western-blot结果显示该重组蛋白均成功融合了6×His标签。为了获得大量的目的蛋白，优化了诱导剂浓度、起始诱导菌体浓度及诱导时间等表达条件。此外，建立了重组蛋白BF2-BSP和Chβ2m在变性状态下通过镍柱亲和层析纯化包涵体的方法，获得了高纯度的重组蛋白BF2-BSP和Chβ2m。
根据文献所报道，合成了鸡传染性支气管炎病毒(IBV)核蛋白N_(71-78)T细胞表位肽，将其与纯化后的重组蛋白BF2-BSP和Chβ2m在重折叠缓冲液中复性。复性后在快速蛋白液相色谱仪(FPLC)上分离出复性组装成功的BF2/肽单体复合物。将该单体复合物在体外进行生物素化，其产物再次采用FPLC通过分子筛分离出生物素化后的BF2/肽单体复合物；通过链霉亲和素迁移实验检测体外生物素化效率，然后将生物素化后的BF2/肽单体复合物与藻红蛋白(PE)标记的链霉亲和素按一定比例反应生成BF2/肽四聚体。
为了检测所制备BF2/肽四聚体的功能，采用10~(5.5)EID_(50)的IBV H52株接种一周龄SPF鸡，10d后采抗凝血用淋巴细胞分离液分离PBMC，调整细胞浓度后取1×10~6个细胞进行抗鸡CD8单抗和BF2/肽四聚体双色荧光染色，采用流式细胞术检测并分析染色结果，结果表明所制备的BF2/肽四聚体可用于检测IBV N蛋白特异性T淋巴细胞，检测一周龄SPF鸡接种H52后10d时针对N蛋白的特异性T细胞比率为3.65％。
为了探讨SPF鸡在感染IBV后体内抗体水平及针对N蛋白特异性的T淋巴细胞的动态变化，将125羽SPF鸡随机分为三组分别作为接种免疫组、攻毒对照组和空白对照组。采用IBV H52标准毒株对其通过滴鼻方式进行免疫，之后每3天剖杀5羽观察各脏器的病理学变化、检测血清抗体效价并采用BF2/肽四聚体评价其N蛋白特异性T细胞的比例；免疫15d时采用IBV M41对免疫组和攻毒对照组进行攻毒，同样检测上述指标。最后综合评价IBV在免疫及攻毒后血清抗体和
N蛋白特异性T细胞的动态变化趋势及两者之间的相互关系。检测结果表明H52滴鼻免疫后特异性T细胞免疫的产生早于血清抗体IgG的出现，攻毒结果显示在SPF鸡未产生坚强的体液免疫时仍能抵抗同型强毒的攻击，提示特异性T细胞在抵抗IBV早期感染免疫反应过程中可能起着重要作用。
The major histocompatibility complex classⅠ(MHC classⅠ) peptide tetramer is a sensitive tool to evaluate antigen-specific cytotoxic T lymphocytes(CTLs). However, no chicken MHC classⅠpeptide tetramer has been reported by now.
In order to construct the chicken MHC classⅠpeptide tetramer, genes of the chicken MHCⅠαchain(BF2*15) andβ2 microglobulin(Chβ2m) were amplified from the total RNA of peripheral blood monouclear cells(PBMCs) by RT-PCR and cloned into pMD18-T. Then the PCR products deleted the signal sequence at the 5' end of both the BF2 and Chβ2m genes and included the BirA substrate peptide(BSP) sequence at the 3' end of the BF2 gene were sub-cloned into the expression vector pET-28a(+) and named as pET-BF2-BSP and pET-Chβ2m. High levels of BF2-BSP and Chβ2m proteins were successfully expressed in E. coli strain BL21(DE3) transformed with the recombinant vectors pET-BF2-BSP and pET-Chβ2m. The recombinant target proteins were purified with a Ni~(2+)NTA column including His-Bind Resin, and then high-quality recombinant proteins were recovered.
BF2-BSP and Chβ2m were refolded with synthetic peptide originated from infectious bronchitis virus nucleoprotein(IBV N_(71-78)) in refolding buffer to generate the monomer of BF2/peptide complex. The folded product was then subjected to enzymatic biotinylation by BirA enzyme. After biotinylation the sample was run over a gel filtration column to purify the BF2/peptide fraction. The tetrameric complexes of biotinylated BF2/peptide were produced by mixing purified, biotinylated monomer with PE-labeled streptavidin at a molar ratio of 4:1.
In order to test the function of the prepared BF2/peptide tetramer, one-week SPF chicks were immunized with 10~(5.5)EID_(50) IBV H52 strain through intranasal inoculation. The PBMCs were isolated at 10 days post infection(d.p.i.) and used for flow cytometry staining. The CTLs response of IBV-infected chicks was evaluated with the prepared BF2/peptide tetramer and 3.65% CTLs frequency specific to IBV N was detected.
To discuss the kinetics of the antibody titer and the IBV N-specific T cell when the SPF chicks were infected with the IBV, 125 SPF chicks were divided into three groups at random, namely vaccinated group, challenge control group and negative control group. The SPF chicks from the vaccinated group were immunized with 10~(5.5)EID_(50) IBV H52 strain through intranasal inoculation. Five chicks were sacrificed every three days for pathogenesis observation, assessment of antibody titer and IBV N-specific T cell measured by prepared BF2/peptide tetramer. The chicks from vaccinated group and challenge control group were challenged with IBV M41 at the day 15 after vaccination. Also, the same assessments were taken on as described above. All the results were pooled together to investigate the interaction between the antibody titer and nucleoprotein-specific T cell after vaccination and challenge.
The results indicated that the CTL activity was shown to be effective during the initial elimination of virus in the chicks, later control of infection probably depends on antibody, especially the IgG response, which likely plays a important role in preventing recrudescence of infection.
引文
1．陈建飞．鸡传染性支气管炎病毒中国主要疫苗株的分子特性，[硕士学位论文]．北京：中国农业科学院，2005．
2．丁红梅，周继勇，于涟．鸡传染性支气管炎病毒N基因及其编码产物的分子生物学．预防兽医学进展2001，3(1)：1～4．
3．何贤辉，徐丽慧，刘毅，曾耀英．人β2-微球蛋白基因克隆及其在大肠杆菌中的高效表达．中国生物工程学报2004，20(1)：99～103．
4．刘光亮，童铁钢，孟庆文，吴东来．鸡β_2微球蛋白基因克隆及其在大肠杆菌中的高效表达．中国兽医学报，2007，27(5)：1～4．
5．刘光亮，童铁钢，王群，肖一红，孟庆文，吴东来．鸡MHC Ⅰ α-生物素化序列融合基因的构建、表达及纯化．农业生物技术学报，2006，14(5)：662～668．
6．刘思国，康丽娟，江国托，孔宪刚，卢中冶，刘忠贵，卢景良．鸡传染性支气管炎病毒核蛋白基因重组真核表达载体的构建，中国兽医学报2001，21(1)：14～16．
7．钱丽，钱书兵，钱关祥．可生物素化HLA-A2-生物素化序列融合基因的构建与表达．上海免疫学杂志2002，22(1)：26～29．
8．钱丽，钱书兵，钱关祥．人β2-微球蛋白基因的克隆与表达．细胞与分子免疫学杂志2001，17(4)：384～385．
9. Alexander D.J., Gough R.E., Pattison M.. A long-term study of the pathogenesis of infection of fowls with 3 strains of avian infectious bronchitis virus. Research of Veterinary Science 1978, 24(2): 223～227.
10. Allen G.M., Yeargan L.R., Costa R. and Cross R.. Major histocompatibility complex class Ⅰ-restricted cytotoxic T-lymphocyte response in horses infected with equine herpesvirus. Journal of Virology 1995, 69(1): 606-612.
11. Altman J.D., Moss P.A.H., Goulder P.J.R., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., Davis M.M.. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996, 274 (5284): 94～96.
12. Appay V., Rowland-Jones S.L., The assessment of antigen-specific CD8＋ T cells through the combination of MHC class Ⅰ tetramer and intracellular staining. Journal of Immunological Methods 2002,268(1) ,9～19．
13． Asemissen A.M.,Nagorsen D.,Keilholz U.,Letsch A.,Schmittel A.,Thiel E.,Scheibenbogen C.Flow cytometric determination of intracellular or secreted IFN-γ for the quantification of antigen reactive T cells.Journal of Inummological Methods 2001,251(1-2) :101～108．
14． Bendtsen,J.D.,Nielsen,H.,Heijne,G.,Brunak,S..Improved prediction of signal peptides:SignalP 3． 0． Journal of Molecular Biology.2004,340(4) :783～795．
15． Binns M.M.,Boursnell M.E.G.,Cavanagh D.,Pappin D.J.C.,Brown T.D.K..Cloning and sequencing of the gene encoding the spike protein of the coronavirus IBV.Journal of General Virology 1985,66(4) :719～726．
16． Boots A.M.,Benaissa-Trouw B.J..Hesselink W.,Rijke E.,Schrier C,Hensen E.J..Induction of anti-viral immune responses by immunization with recombinant-DNA encoded avian coronavirus nucleocapsid protein.Vaccine 1992(2) ,10:119～124．
17． Boots A.M.,Kusters J.G,van Noort J.M.,Zwaagstra K.A.,Rijke E.,van der Zeijst B.A.,Hensen E.J..Localization of a T-cell epitope within the nucleocapsid protein of avian coronavirus.Immunology 1991b,74(1) :8～13．
18． Boots A.M.,Van Lierop M.J.,Kusters J.G,Van Kooten P.J.,Van der Zeijst B.A.,Hensen E.J..MHC class Ⅱ-restricted T-cell hybridomas recognizing the nucleocapsid protein of avian coronavirus IBV.Immunology 1991a,72(1) :10～14．
19． Borysiewicz L.K.,Fiander A.,Nimako M.,Man S.,Wilkinson G.W.,Westmoreland D.,Evans A.S.,Adams M.,Stacey S.N.,Boursnell M.E.,Rutherford E.,Hickling J.K.,Inglis S.C..A recombinant vaccinia virus encoding human papillomavirus types 16 and 18,E6 and E7 proteins as immunotherapy for cervical cancer.Lancet 1996,347(9014) :1523～1527．
20． Briles W.E.,Goto R.M.,Auffray C,Miller M.M..A polymorphic system related to but genetically independent of the chicken major histocompatibility complex.Immunogenetics 1993,37(6) :408～414．
21． Brunner K.T.,Mauel J.,Cerottini J.C.,Chapuis B..Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelied allogeneic target cells in vitro;inhibition by isoantibody and by drugs.Immunology 1968,14(2) :181～196．
22． Busch D.H.,Pilip I.,Pamer E.G..Evolution of a complex TCR repertoire during primary and recall bacterial infection.The Journal of Experimental Medicine 1998,188(1) :61～70．
23． Busch,D.,Pamer E..T lymphocyte dynamics during Listeria monocytogenes infection. Immunology Letters 1999, 65(1-2): 93～8.
24. Busch, D.H., Kerksiek K.M., Pamer E.G.. Processing of Listeria monocytogenes antigens and the in vivo T cell response to bacterial infection. Immunology Reviews 1999, 172(2): 163～169.
25. Busch, D.H., Pamer E.G.. T cell affinity maturation by selective expansion during infection. The Journal of Experimental Medicine 1999, 189(4): 701～710.
26. Busch, D.H., Pilip I.M., Vijh S., Pamer E.G.. Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity 1998, 8(3): 353-362.
27. Callan M.F., Tan L., Annels N., Ogg G.S., Wilson J.D., O'Callaghan C.A., Steven N., McMichael A.J., Rickinson A.B.. Direct visualization of antigen-specific CD8~+ T cells during the primary immune response to Epstein-Barr virus in vivo. Journal of Experimental Medicine 1998, 187(9): 1395～1402.
28. Cavanagh D., Davis P.J., Mockett A.P.. Amino acids within hypervariable region 1 of avian coronavirus IBV (Massachusetts serotype) spike glycoprotein are associated with neutralization epitopes. Virus Research 1988, 11(2): 141～150.
29. Cavanagh D.. Nidovirales: a new order comprising Coronaviridae and Arteriviridae. Archives of Virology 1997, 142(3): 629～633.
30. Cavanagh D.. Severe acute respiratory syndrome vaccine development; experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathology, 2003, 32 (6): 567～582.
31. Chen B.Y., Itakura C. Cytopathology of chick renal epithelial cells experimentally infected with avian infectious bronchitis virus, Avian Pathology 1996, 25(4):675～694.
32. Collins R.W.. Human MHC class I chain related (MIC) genes: their biological function and relevance to disease and transplantation. European Journal of Immunogenetics 2004, 31(3): 105～114.
33. Collission E.W, Pei J., Dzielawa J., Sao S.H.. Cytotoxic T lymphocytes are critical in control of infectious bronchitis virus in poutry. Developmental and Comparative Immunology 2000, 24(2-3): 187～200.
34. Collisson E.W., Parr R.L., Li W., Williams A.K.. An overview of the molecular characteristics of avian infectious bronchitis virus. Poultry Science Review 1992, 4(1): 41～55.
35. Corr M., Slanetz A.E., Boyd L.F., Jelonek M.T., Khilko S., al-Ramadi B.K., Kim Y.S., Maher S.E., Bothwell A.L., Margulies D.H.. T cell receptor-MHC class Ⅰ peptide interactions: affinity, kinetics, and specificity. Science 1994, 265 (5174): 946～949.
36． Crinion R.A.P.,Hofstad M.S..Pathogenicity of four serotypes of avian infectious bronchitis virus for the oviduct of young chickens of various ages.Avian Disease 1972,16(2) :351～363．
37． Di Fabio S.,Mbawuike I.N.,Kiyono H.,Fujihashi K..,Couch R.B.,McGhee J.R..Quantitation of human influenza virus-specific cytotoxic T lymphocytes:correlation of cytotoxicity and increased numbers of IFN-gamma producing CD8~+ T cells.International Immunology 1994,6(1) :11～19．
38． Doherty P.C.,Blanden R.B.,and Zinkernagel R.M..Specificity of virus-immune effector T cells for H-2K or H-2D compatible interactions:implications for H-antigen diversity.Transplant Review 1976,29:89～124．
39． Dohlsten M.,Sundstedt A.,Bjorklund M.,Hedlund G.,Kalland T..Super-antigen induced cytokines suppress growth of human colon-carcinoma cells.International Journal of Cancer 1993,54(3) :482～488．
40． Donahoe S.M.,Moretto W.J.,Samuel R.V.,Metzner K.J.,Marx P.A.,Hank T.,Connor R.I.,Nixon D.F..Direct measurement of CD8~+T cell responses in macaques infected with simian immunodeficiency virus.Virology 2000,272(2) :347～356．
41． Donahoe S.M.,Moretto W.J.,Samuel R.V.,Metzner K.J.,Marx P.A.,Hanke T.,Connor R.I.,Nixon D.F..Direct measurement of CD8+ T cell responses in macaques infected with simian immunodeficiency virus.Virology 2000,272(2) :347～356．
42． Dunbar P.R.,Ogg G.S.,Chen J.,Rust N.,van der Bruggen P.,Cerundolo V..Direct isolation,phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood.Current Biology 1998,8(7) :413～416
43． Echchakir H.,Dorothe G.,Vergnon I.,Menez J.,Chouaib S.,Mami-Chouaib F..Cytotoxic T lymphocytes directed against a tumor-specific mutated antigen display similar HLA tetramer binding but distinct functional avidity and tissue distribution.Proceeding of the National Academy of Sciences of the United States of America 2002,99(14) :9358～9363．
44． Egan M.A.,Pavlat W.A.,Tartaglia J.,Paoletti E.,Weinhold K.J.,Clements M.L.,Siliciano R.F..Induction of human immunodeficiency virus type 1(HIV-1) -specific cytolytic T lymphocyte responses in seronegative adults by a nonreplicating,host-range-restricted canaiypox vector(ALVAC)carrying the HIV-1 MN env gene.Journal of Infectious Disease 1995,171(6) :1623～1627．
45． Eliana D.B.C..Refolding of recombinant proteins.Current Opinion in Biotechnology 1998,9(2) :157～163．
46． Engstrand M.,Tournay C,Peyrat M.A.,Eriksson Britt-Marie,Wadstrom J.,Wirgart B.Z.,Romagne F.,Bonneville M.,Totterman T.H.,Korsgren O..Characterization of CMVpp65-Specific CD8~+ T Lymphocytes using MHC Tetramers in Kidney Transplant Patients and Health Participants.Transplantation 2000． 69(11) :2243～2250．
47． Fischer K.,Andreesen R.,Mackensen A..An improved flow cytometric assay for the determination of cytotoxic T lymphocyte activity.Journal of Inummological Methods 2002,259(1-2) :159～169．
48． Gallimore A.,Glithero A.,Godkin A.,Tissot A.C.,Plückthun A.,Elliott T.,Hengartner H.,Zinkernagel R..Induction and Exhaustion of Lymphocytic Choriomeningitis Virus-specific Cytotoxic T Lymphocytes Visualized Using Soluble Tetrameric Major Histocompatibility Complex Class I-Peptide Complexes.Journal of Experimental Medicine 1998,187(9) :1383-1393．
49． Garboczi D.N.,Hung D.T.,Wiley D.C..HLA-A2-peptide complexes:Refolding and crystallization of molecules expressed in scherichia coli and complexed with single antigenic peptides.Proceeding of the National Academy of Sciences of the United States of America 1992,89(8) :3429～3433
50． Garboczi D.N.,Utz U.,Ghosh P.,Seth A.,Kim J.,VanTienhoven E.A.E.,Biddison W.E.,Wiley D.C..Assembly,specific binding,and crystallization of a human TCR-alpha/beta with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2． The Journal of Immunology 1996,157(12) :5403～5410．
51． Garboczi,D.N.,Gosh P.,Utz U.,Fan Q.R.,Biddison W.E.,Wiley D.C..Structure of the complex between human T-cell receptor,viral peptide and HLAA2． Nature 1996,384(6605) :134～141．
52． Goldberg J.E.,Sherwood S.W.,Clayberger C..A novel method for measuring CTL and NK cell-mediated cytotoxicity using annexin V and two-color flow cytometry.Journal of Inummological Methods 1999,224(1-2) :1～9．
53． Griffioen M.,Borghi M.,Schrier P.I.,Osanto S..Detection and quantification of CD8+ T cells specific for HLA-A*0201-binding melanoma and viral peptides by the IFN-gamma-ELISPOT assay.International Journal of Cancer 2001,93(4) :549～55．
54． Haanen J.B.,Van Oijen M.G.,Tirion F.,Oomen L.C.,Kruisbeek A.M.,Vyth-Dreese F.A.,Schumacher T.N..In situ detection of virus-and tumor-specific T-cell immunity.Nature Medicine 2000,6(9) :1056～1060．
55． Herr W.,Schneider J.,Lohse A.W.,Meyer zum Buschenfelde K.H.,Wolfel T..Detection and quantification of blood derived CD8~+ T lymphocytes secreting tumor necrosis factor alphain response to HLA-A2． 1 binding melanoma and viral peptide antigens.Journal of Inummological Methods 1996,191(2) :131～142．
56． Hofstad M.S..Avian infectious bronchitis.In:Calnek B.W.,Barnes H.J.,Beard C.W.,Reid W.M.,Yoder H.W.,editors.Diseases of poultry.Ames,IA:Iowa State University Press,1984． p.429～243[8~(th) ed.].
57． Hogquist K.A.,Jameson S.C.,Heath W.R.,Howard J.L.,Bevan M.J.,Carbone F.R..T cell receptor antagonist peptides induce positive selection.Cell 1994． 76(1) :17～27．
58． Hugues S.,Malherbe L.,Filippi,Glaichenhaus N..Generation and use of alternative multimers of peptide pMHC complexes.Journal of Immunological Methods 2002,268(1) :83～92
59． Ignjatovic J.,Galli L..The S1 glycoprotein but not the N or M proteins of avian infectious bronchitis virus induces protection in vaccinated chickens.Archives of Virology 1994,138(1-2) :117～134．
60． Ikemura,T.Codon usage and tRNA content in unicellular and multicellular organisms.Molecular Biology and Evolution.1985,2(1) :13～34．
61． Jager E.,Hohn H.,Necker A.,Forster R.,Karbach J.,Freitag K.,Neukirch C.,Castelli C,Salter R.D.,Knuth A.,Maeurer M.J.Peptide-specific CD8~+ T cell evolution vivo:response to peptide vaccination with Melan-A/MART-1． International Journal of Cancer 2002,98(3) :376～388。
62． Jauknecht R.,Martynoff G.,Lou J.,Hipskind R.A.,Nordheim A.,Stunnenberg H.G..Rapid and efficient purification of native histidine tagged protein expressed by recombinant vaccinia virus.Proceeding of the National Academy of Sciences of the United States of America 1991,88(20) :8972～8976．
63． Jung T.,Schauer U.,Heusser C.,Neumann C.,Rieger C..Detecion of intracellular cytokines by flow cytometry.Journal of Immunological Methods 1993,159(1-2) :197～207．
64． Kalergis A.M.,Goyarts E.C.,Palmieri E.,Honda S.,Zhang W.,Nathenson S.G..A simplified procedure for the preparation of MHC/peptide tetramers:chemical biotinylation of an unpaired cysteine engineered at C-terminus of MHC-I.Journal of Immunological Methods 2000,234(1-2) :61～67．
65． Kaufman J.,Andersen R.,Avila D.,Engberg J.,Lambris J.,Salomonsen J.,Welinder K,Skjodt K..Different features of the MHC class I heterodimer have evolved at different rates.Chicken B-F and beta 2-microglobulin sequences reveal invariant surface residues.Journal of Immunology.1992,148(5) :1532～1546．
66． Kaufman J.,Milne S.,Gobel T.W.,Walker B.A.,Jacob J.P.,Auffray C,Zoorob R.,Beck S..The chicken B locus is a minimal essential major histocompatibility complex.Nature 1999,401(6756) :923～925．
67． Koch G,Hartog L.,Kant A.,van Roozelaar D.J..Antigenic domains on the peplomer protein of avian infectious bronchitis virus:correlation with biological functions.Journal of General Virology 1990,71(9) :1929～1935．
68． Kotani T.,Wada S.,Tsukamoto Y.,Kuwamura M.,Yamate J.,Sakuma S..Kinetics of lymphocytic subsets in chicken tracheal lesions Infected wit h infectious bronchitis virus.Veterinary Medicine Science,2000,62(4) :379～401．
69． Kozlowski S,Takeshita T,Boehncke WH,Takahashi H,Boyd LF,Germain RN,Berzofsky JA,Margulies DH.Excess β2-microglobulin promoting functional peptide association with purified soluble class I MHC molecules.Nature,1991,349(6304) :74～77．
70． Laitinen O.H.,Marttila A.T.,Airenne K.J.,Kulik T.,Livnah O.,Bayer E.A.,Wilchek M.,Kulomaa M.S..Biotin induces tetramerization of a recombinant monomeric avidin.The Journal of Biological Chemistry 2001,276(11) :8219～8224．
71． Lechnera F.,Wongc D.K.H.,Rod Dunbarb R,Chapmana R.,Chungd R.T.,Dohrenwendc R,Robbinsc G,PhillipsaR.,Klenermana R,Walkerc B.D..Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus.Journal of Experimental Medicine 2000,191(9) :1499～1512．
72． Lecoeur H.,Fevrier M.,Garcia S.,Riviere Y.,Gougeon M.L..A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity.Journal of Inummological Methods 2001,253(1-2) :177～187．
73． Lenstra J.A.,Kusters J.G.,Koch G.,van der Zeijst B.A.M.Antigenicity of the peplomer protein of infectious bronchitis virus.Molecular Immunology 1989,26(1) :7～15．
74． Lin Y.L.,and Askonas B.A..Biological properties of an influenza A virus-specific killer T-cell clone.Journal of Experimental Medicine 1981,154(2) :225～234．
75． Liu C.P.,Jiang K.,Wu C.H.,Lee W.H.,Lin W.J..Detection of glutamic acid decarboxylase-activated T cells with I-Ag7 tetramers.Proceeding of National Academy of Science of the United States of America 2000,97(26) :14596～14601．
76． Liu D.X.,lnglis S.C..Association of the infectious bronchitis virus 3c protein with the virion envelope.Virology 1991,185(2) :911～917．
77． Lomniczi B.Biological properties of avian coronavirus RNA.Journal of General Virology 1977,36(3) :531～533．
78． Lucio B.,Fabricant J..Tissue tropism of three cloacal isolates and Massachusetts strain of infectious bronchitis virus.Avian Disease 1990,34(4) :865～870．
79． Maier B.,Buhring H.J.,Simon M.,Eichmann K.,Melchers I..Limiting dilution analysis of proliferating and helper T cells in the in vivo immune response to K.LH:derepression of helper T cells at moderately increased frequencies.Journal of Molecular and Cellular Immunology 1986,2(5) :293～305．
80． Maile R.,Wang B.,Schooler W.,Meyer A.,Collins E.J.,Frelinger J.A..Antigen-specific modulation of an immune response by in vivo administration of soluble MHC class Ⅰ tetramers.Journal of Immunology 2001,167(7) :3708～3714．
81． Mallone R.,Nepom GT..MHC Class Ⅱ tetramers and the pursuit of antigen-specific T cells:define,deviate,and delete.Journal Clinical Immunology,2004,110(3) :232～242．
82． Mamalaki C,Elliott J.,Norton T.,Yannoutsos N.,Townsend A.R.,Chandler P.,Simpson E.,Kioussis D..Positive and negative selection in transgenic mice expressing a T-cell receptor specific for influenza nucleoprotein and endogenous superantigen.Developmental Immunology 1993,3(3) :159～174．
83． Matsui K.,Boniface J.J.,Reay P.A.,Schild H.,Fazekas de St Groth B.,Davis M.M..Low affinity interaction of peptide-MHC complexes with T cell receptors.Science 1991,254(5039) :1788～1791．
84． McMichael A.J.,Kelleher A..The arrival of HLA class Ⅱ tetramers.Journal of Clinical Investigation 1999,104(12) :1669-1670．
85． McMichael,A.,O'Callaghan C..A new look at T cells.The Journal of Experimental Medicine 1998,187(9) :1367～1371．
86． McNeal M.M.,Barone K.S.,Rae M.N.,and Ward R.L..Effector functions of antibody and CD81 cells in resolution of rotavirus infection and protection against reinfection.Virology 1995,214(11) :387～397．
87． Mealey R.H.,Sharif A.,Ellis S.A.,Littke M.H.,Leib S.R.and McGuire T.C.Early detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes.Virology 2005,339(1) :110～126．
88． Meidenbauer N.,Hoffmann T.K.,Donnenberg A.D..Direct visualization of antigen-specific T cells using peptide-MHC-class Ⅰ tetrameric complexes.Methods 2003,31(2) :160～171．
89． Michaelsson J.,Achour A.,Salcedo M.,Kase-Sjostrom A.,Sundback J.,Harris R.A.,Karre K..Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class Ⅰ tetramers.European Journal of Immunology 2000,30(1) :300～307．
90． Miller M.M.,Bacon L.D.,Hala K.,Hunt H.D.,Ewald S.J.,Kaufman J.,Zoorob R.,Briles W.E..Nomenclature for the chicken major histocompatibility(B and Y)complex.Immunogenetics 2004,56(4) :261～79．
91． Miller M.M.,Goto R.,Bernot A.,Zoorob R.,Auffray C,Bumstead N.,Briles W.E..Two MHC class Ⅰ and two MHC class Ⅱ genes map to the chicken Rfp-Y system outside the B complex.Proceeding National Acad Sciences 1994,91(10) :4397～4401．
92． Mondal S.P.,Naqi S.A..Maternal antibody to Infectious bronchitis virus:its role in protection against infection and development of active immunity to vaccine.Veterinary,2001,79(1-2) :31～40．
93． Murali-Krishna K.,Altman J.D.,Suresh M.,Sourdive D.J.,Zajac A.J.,Miller J.D.Slansky J.,Ahmed R..Counting antigen-specific CD8 T cells:a reevaluation of bystander activation during viral infection.Immunity 1998,8(2) :177～187．
94． Niesters H.G.M.,Bleumink-Pluym N.M.,Osterhaus A.D,Horzinek M.C.,van der Zeijst B.A..Epitopes on the peplomer protein of infectious bronchitis virus strain M41 as defined by monoclonal antibodies.Virology 1987,161(2) :511～519．
95． Nociari M.M.,Shalev A.,Benias P.,Russo C..A novel one-step,highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity.Journal of Inummological Methods 1998,213(2) :157～167．
96． Novak E.J.,Liu A.W.,Gebe J.A.,Falk B.A.,Nepom G.T.,Koelle D.M.,Kwok W.W..Tetramer-guided epitope mapping:rapid identification and characterization of immunodominant CD4+T cell epitopes from complex antigens.Journal of Immunology 2001,166(11) :6665～6670．
97． Oleksiewicz M.B.,Kristensen B..Ladekj?r-Mikkelsen A.S.,Nielsen J..Development of a rapid in vitro protein refolding assay which discriminates between peptide-bound and peptide-free forms of recombinant porcine major histocompatibility class Ⅰ complex(SLA-I).Veterinary Immunology and Immunopathology 2002,86(1-2) :55～77．
98． Otten G.R.,Bikoff E.,Ribaudo R.K.,Kozlowski S.,Margulies D.H.,Germain R.N..Peptide and β2-microglobulin regulation of cell surface MHC class Ⅰ conformation and expression.Journal of Immunology 1992,148(12) :3723～3732．
99． Owen J.A.,Allouche M.,Doherty PC..Limiting dilution analysis of the specificity of influenza-immune cytotoxic T cells.Cell Immunology 1982,67(1) :49～59．
100． Pala P.,Hussell T.,Openshaw P.J.M..Flow cytometric measurement of intracellular cytokine.Journal of Inummological Methods 2000,243(1-2) :107～124
101． Parker K.C.,Silver M.L.,Wiley D.C..An HLA-A2/Pbeta2-microglobulin/peptide complex assembled from subunits expressed separately in Escherichia coli.Molecular Immunology 1992,29(3) :371～378．
102． Piao W.,Song X.,Liu M.,He Y.,Zhang H.,Xu W.,Li Z.,Zhang H.,Ling S.,Wang G..Cloning,expression,and purification of HLA-A2-BSP and β2m in Escherichia coli.Protein Expression and Purification 2004,35(2) :210～217．
103． Prussin C.,Metcalfe DD.Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies.Journal of Inummological Methods 1995,188(1) :117～128．
104． Rehermann B.,Chang K.M.,McHutchison J.,Kokka R.,Houghton M.,Rice C.M.,Chisari F.V..Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients.Journal of Virology 1996,70(10) :7092～7102．
105． Rehermann B.,Chang K.M.,McHutchison J.,Kokka R.,Houghton M.,Rice CM.,Chisari F.V..Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.Journal of Clinical Investigation 1996,98(6) :1432～1440．
106． Reignat S.,Webster G.J.,Brown D.,Ogg G.S.,King A.,Seneviratne S.L.,Dusheiko G.,Williams R.,Maini M.K.,Bertoletti A..Escaping high viral load exhaustion:CD8 cells with altered tetramer binding in chronic hepatitis B virus infection.Journal of Experimental Medicine 2002,195(9) :1089～1101．
107． Reusser,P.,Riddell S.R.,Meyers J.D.,and Greenberg P.D..Cytotoxic T lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation:pattern of recovery and correlation with cytomegalovirus infection and disease.Blood 1991,78(5) :1373～1380．
108． Robert B.,Guillaume P.,Luescher I.,Romero P.,Mach J.P..Antibody-conjugated MHC class Ⅰ tetramers can target tumor cells for specific lysis by T lymphocytes.European Journal of Immunology 2000,30(11) :3165～3170．
109． Roden M.M.,Lee K.H.,Panelli M.C.,Marincola F.M..A novel cytolysis assay using Fluorescent labeling and quantitative fluorescent scanning technology.Journal of Inummological Methods 1999,226(1-2) :29～41．
110． Schagger H.,Jagow G.V..Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.Analytical Biochemistry 1987,166(2) :368～379．
111． Schatz J..Use of peptide libraries to map the substrate of a peptide modifying enzyme:A 13 residue consensus peptide specifies biotinylation in Escherichia coli.Biotechnology 1993,11:1138～1143．
112． Schatz,P.J.Use of peptide libraries to map the substrate specificity of apeptide modifying enzyme:a 13 residue consensus peptide specifies biotinylation in Escherichia coli.Biotechnology 1993,11(10) :1138～1143．
113． Scheibenbogen C,Lee K.H.,Mayer S.,Stevanovic S.,Moebius U.,Herr W.,Rammensee H.G.,Keilholz U..A sensitive ELISPOT assay for detection of CD8+ T lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients.Clinical Cancer Research 1997,3(2) :221～226．
114． Scheibenbogen C,Lee K.H.,Stevanovic S.,Witzens M.,Willhauck M.,Waldmann V.,Naeher H.,Rammensee H.G.,Keilholz U..Analysis of the T cell response to tumor and viral peptide antigens by an IFN gamma-ELISPOT assay.International Journal of Cancer 1997,71(6) :932～936．
115． Scheibenbogen C.,Romero P.,Rivoltini L.,Herr W.,Schmittel A.,Cerottini J.C.,Woelfel T.,Eggermont A.M.,Keilholz U..Quantitation of antigen-reactive T cells in peripheral blood by IFN-gamma-ELISPOT assay and chromium-release assay:a four-centre comparative trial.Journal of Immunological Methods 2000,244(1-2) :81～89．
116． Schneider J.,Gilbert S.C.,Blanchard T.J.,Hanke T.,Robson K.J.,Hannan CM.,Becker M.,Sinden R.,Smith G.L.,Hill A.V..Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.Nature Medicine 1998,4(4) :397～402．
117． Schochetman G.,Stevens R.H.,Simpson R.W..Presence of infectious polyadenylated RNA in the coronavirus avian bronchitis virus.Virology 1977,77(2) :772～782．
118． Seah J.N.,Yu L.and Kwang J..Localization of linear B cell epitopes on infectious bronchitis virus nucleocapsid protein.Veterinary Microbiology 2000,75(1) :11～16．
119． Seo H.S.,Collisson E.W..Specific cytotoxic T lymphocytes are involved in in vivo clearance of infectious bronchitis virus.Journal of Virology 1997,71(7) :5173～5177．
120． Seo U.S.,Wang L.,Smith R..The carboxy-terminal 120-residue polypeptide of infectious bronchitis virus from nucleocapsid induces cytotoxic T lymphocytes and protects chickens from acute infection.Journal of Virology 1997,71(10) :7889～7894．
121． Seo,S.H.,Pei J.,Briles W.E.,Dzielawa J.,Collisson E.W..Adaptive transfer of infectious bronchitis virus primed αβ T cells bearing CD8 antigen protects chicks from acute infection.Virology 2000,269(1) :183～189．
122． Serbina N.,Pamer E.G.Quantitative studies of CD8+ T-cell responses during microbial infection.Current Opinion in Immunology 2003,15(4) :436～442．
123． Sha W.C.,Nelson C.A.,Newberry R.D.,Kranz D.M.,Russell J.H.,Loh D.Y..Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice.Nature 1988,335(6187) :271～274．
124． Shalk AF,Hawn MC.An apparently new respiratory disease of baby chicks.Journal of American Veterinary Medical Association 1931,78:413～422．
125． Sharrock C.E.,Kaminski E.,Man S..Limiting dilution analysis of human T cells:a useful clinical tool.Immunology Today 1990,11(8) :281～286．
126． Shields M.J.,Assefi N.,Hodgson W.,Kim E.J.,Ribaudo R.K..Characterization of the interactions between MHC class I subunits:a systematic approach for the engineering of higher affinity variants of β2-microglobulin.Journal of Immunology 1998a,160(5) :2297～2307．
127． Shields M.J.,Kubota R.,Hodgson W.,Jacobson S.,Biddison W.E.,Ribaudo R.K..The effect of human β2-microglobulin on major histocompatibility complex I peptide loading and the engineering of a high affinity variant.The Journal of Biological Chemistry 1998b,273(43) :28010～28018．
128． Skinner P.J.,Daniels M.A.,Schmidt C.S.,Jameson S.C.,Haase A.T..Cutting edge:in situ tetramer staining of antigen specific T cells in tissues.Journal of Immunology 2000,165(2) :613～617．
129． Tarbell K.V.,Lee M.,Ranheim E.,Chao C.C.,Sanna M.,Kim S.K.,Dickie P.,Teyton L.,Davis M.,McDevitt H..CD4(+)T cells from glutamic acid decarboxylase(GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer.J Exp Med,2002,196(4) :481～492．
130． Tashiro M,Fujii Y.,Nakamura K.,and Homma M..Cell-mediated immunity induced in mice after vaccination with a protease activation mutant,TR-2,of Sendai virus.Journal of Virology 1988,62(7) :2490～2497．
131． Taswell C..Limiting dilution assays for the determination of immunocompetent cell frequencies I.Data analysis.Journal of Immunology 1981,126(4) :1614～1619．
132． Thacker E.L.,Fulton J.E.,and Hunt H.D..In vitro analysis of a primary,major histocompatibility complex(MHC)-restricted,cytotoxic Tlymphocyte response to avian leukosis virus(ALV),using target cells expressing MHC class Ⅰ cDNA inserted into a recombinant ALV vector.Journal of Virology 1995,69(10) :6439-6444．
133． Tobias J.W.,Shader T.E.,Rocap G.,Varchavsky A..The N end rule in bacteria.Science 1991,254(5036) :1374～1377．
134． Toes R.E.,Offringa R.,Blom R.J.,Melief C.J.,Kast W.M..Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.Proceeding of National Academy of Science of the United States of America 1996,93(15) :7855～7860．
135． Tora H.,Espinoza C,Ponce V.,Rojas V.,Morales M.A.,Kaleta E.F..Infectious bronchitis effect of viral dose and routes on specific lacrimal and serum antibody response in chickens.Avian Disease,1997,4(2) :379～387．
136． Townsend A.,and Bodmer H..Antigen recognition by class I-restricted T lymphocytes.Annually Review of Immunology 1989,7(4) :601-624．
137． Tsang K.Y.,Zaremba S.,Nieroda C.A.,Zhu M.Z.,Hamilton J.M.,Schlom J..Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine.Journal of the National Cancer Institute 1995,87(13) :982～990．
138． Walter J.B.,Garboczi D.N.,Fan Q.R.,Zhou X.,Walker B.D.,Eisen H.N..A mutant human β2-microglobulin can be used to generate diverse multimeric class I peptide complexes as specific probes for T cell receptors.Journal of Immunological Methods 1998,214(1-2) :41～50．
139． Wang B.,Chen H.,Cao X.,Jiang X.,Zhang M.,Wan T.,Li N.,Zhou X.,Wu Y.,Yang F.,Yu Y.,Wang X.,Yang R..Identification of an HLA-A*0201-restricted CD8+T-cell epitope SSp-1 of SARS-CoV spike protein.Blood 2004,104(1) :200～206．
140. Weber S., Traunecker A., Oliveri F., Gerhard W., Karjalainen K.. Specific low-affinity recognition of major histocompatibility complex plus peptide by soluble T-cell receptor. Nature 1992, 356 (6372): 793～796.
141. Wilson J.D., Ogg G.S., Allen R.L., Chao C.C., Sanna M., Kim S.K., Dickie P., Teyton L., Davis M., McDevitt H.. Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection. AIDS, 2000(3), 14: 225～233.
142. Wolfl M., SchalkS., Hellmich M., Huster K.M., BuschD.H., Berthold F. Quantitation of MHC tetramer-positive cells from whole blood: evaluation of a single-platform, six-parameter flow cytometric method. Cytometry 2004, 57(2): 120～130.
143. Yang J., Jaramillo A., Shi R., Kwok W.W., Mohanakumar T.. In vivo biotinylation of the major histocompatibility complex (MHC) class Ⅱ/peptide complex by coexpression of BirA enzyme for the generation of MHC class Ⅱ/tetramers. Human Immunology 2004, 65(7): 692～699.
144. Yewdell J.W., Bennink J.R.. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes. Science 1989, 244(4908): 1072～1075.
145. Yu L., Liu W., Schnizlein W.M., Frippathy D.N., Kwang J.. Study of protection by recombinant fowl poxvirus expressing C-teminal nucleoeapsid protein of infectious bronchitis virus against challenge. Avian Disease 2001, 45(2): 340～348.
146. Yuriko S., Hiroeki S., Tomohide T., Masako K., Yoshihiko H., Yuki N., Satoshi K., Hideyuki I., Toshihiko T., Shingo I., Yasuaki T., Takuro W., Toshihiko Y., Masashi G., Hideo T., Noriyuki S.. Improved generation of HLA class Ⅰ/peptide tetramers. Journal of Immunological Methods 2002, 271(1-2): 177～184.
2．丁红梅，周继勇，于涟．鸡传染性支气管炎病毒N基因及其编码产物的分子生物学．预防兽医学进展2001，3(1)：1～4．
3．何贤辉，徐丽慧，刘毅，曾耀英．人β2-微球蛋白基因克隆及其在大肠杆菌中的高效表达．中国生物工程学报2004，20(1)：99～103．
4．刘光亮，童铁钢，孟庆文，吴东来．鸡β_2微球蛋白基因克隆及其在大肠杆菌中的高效表达．中国兽医学报，2007，27(5)：1～4．
5．刘光亮，童铁钢，王群，肖一红，孟庆文，吴东来．鸡MHC Ⅰ α-生物素化序列融合基因的构建、表达及纯化．农业生物技术学报，2006，14(5)：662～668．
6．刘思国，康丽娟，江国托，孔宪刚，卢中冶，刘忠贵，卢景良．鸡传染性支气管炎病毒核蛋白基因重组真核表达载体的构建，中国兽医学报2001，21(1)：14～16．
7．钱丽，钱书兵，钱关祥．可生物素化HLA-A2-生物素化序列融合基因的构建与表达．上海免疫学杂志2002，22(1)：26～29．
8．钱丽，钱书兵，钱关祥．人β2-微球蛋白基因的克隆与表达．细胞与分子免疫学杂志2001，17(4)：384～385．
9. Alexander D.J., Gough R.E., Pattison M.. A long-term study of the pathogenesis of infection of fowls with 3 strains of avian infectious bronchitis virus. Research of Veterinary Science 1978, 24(2): 223～227.
10. Allen G.M., Yeargan L.R., Costa R. and Cross R.. Major histocompatibility complex class Ⅰ-restricted cytotoxic T-lymphocyte response in horses infected with equine herpesvirus. Journal of Virology 1995, 69(1): 606-612.
11. Altman J.D., Moss P.A.H., Goulder P.J.R., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., Davis M.M.. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996, 274 (5284): 94～96.
12. Appay V., Rowland-Jones S.L., The assessment of antigen-specific CD8＋ T cells through the combination of MHC class Ⅰ tetramer and intracellular staining. Journal of Immunological Methods 2002,268(1) ,9～19．
13． Asemissen A.M.,Nagorsen D.,Keilholz U.,Letsch A.,Schmittel A.,Thiel E.,Scheibenbogen C.Flow cytometric determination of intracellular or secreted IFN-γ for the quantification of antigen reactive T cells.Journal of Inummological Methods 2001,251(1-2) :101～108．
14． Bendtsen,J.D.,Nielsen,H.,Heijne,G.,Brunak,S..Improved prediction of signal peptides:SignalP 3． 0． Journal of Molecular Biology.2004,340(4) :783～795．
15． Binns M.M.,Boursnell M.E.G.,Cavanagh D.,Pappin D.J.C.,Brown T.D.K..Cloning and sequencing of the gene encoding the spike protein of the coronavirus IBV.Journal of General Virology 1985,66(4) :719～726．
16． Boots A.M.,Benaissa-Trouw B.J..Hesselink W.,Rijke E.,Schrier C,Hensen E.J..Induction of anti-viral immune responses by immunization with recombinant-DNA encoded avian coronavirus nucleocapsid protein.Vaccine 1992(2) ,10:119～124．
17． Boots A.M.,Kusters J.G,van Noort J.M.,Zwaagstra K.A.,Rijke E.,van der Zeijst B.A.,Hensen E.J..Localization of a T-cell epitope within the nucleocapsid protein of avian coronavirus.Immunology 1991b,74(1) :8～13．
18． Boots A.M.,Van Lierop M.J.,Kusters J.G,Van Kooten P.J.,Van der Zeijst B.A.,Hensen E.J..MHC class Ⅱ-restricted T-cell hybridomas recognizing the nucleocapsid protein of avian coronavirus IBV.Immunology 1991a,72(1) :10～14．
19． Borysiewicz L.K.,Fiander A.,Nimako M.,Man S.,Wilkinson G.W.,Westmoreland D.,Evans A.S.,Adams M.,Stacey S.N.,Boursnell M.E.,Rutherford E.,Hickling J.K.,Inglis S.C..A recombinant vaccinia virus encoding human papillomavirus types 16 and 18,E6 and E7 proteins as immunotherapy for cervical cancer.Lancet 1996,347(9014) :1523～1527．
20． Briles W.E.,Goto R.M.,Auffray C,Miller M.M..A polymorphic system related to but genetically independent of the chicken major histocompatibility complex.Immunogenetics 1993,37(6) :408～414．
21． Brunner K.T.,Mauel J.,Cerottini J.C.,Chapuis B..Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelied allogeneic target cells in vitro;inhibition by isoantibody and by drugs.Immunology 1968,14(2) :181～196．
22． Busch D.H.,Pilip I.,Pamer E.G..Evolution of a complex TCR repertoire during primary and recall bacterial infection.The Journal of Experimental Medicine 1998,188(1) :61～70．
23． Busch,D.,Pamer E..T lymphocyte dynamics during Listeria monocytogenes infection. Immunology Letters 1999, 65(1-2): 93～8.
24. Busch, D.H., Kerksiek K.M., Pamer E.G.. Processing of Listeria monocytogenes antigens and the in vivo T cell response to bacterial infection. Immunology Reviews 1999, 172(2): 163～169.
25. Busch, D.H., Pamer E.G.. T cell affinity maturation by selective expansion during infection. The Journal of Experimental Medicine 1999, 189(4): 701～710.
26. Busch, D.H., Pilip I.M., Vijh S., Pamer E.G.. Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity 1998, 8(3): 353-362.
27. Callan M.F., Tan L., Annels N., Ogg G.S., Wilson J.D., O'Callaghan C.A., Steven N., McMichael A.J., Rickinson A.B.. Direct visualization of antigen-specific CD8~+ T cells during the primary immune response to Epstein-Barr virus in vivo. Journal of Experimental Medicine 1998, 187(9): 1395～1402.
28. Cavanagh D., Davis P.J., Mockett A.P.. Amino acids within hypervariable region 1 of avian coronavirus IBV (Massachusetts serotype) spike glycoprotein are associated with neutralization epitopes. Virus Research 1988, 11(2): 141～150.
29. Cavanagh D.. Nidovirales: a new order comprising Coronaviridae and Arteriviridae. Archives of Virology 1997, 142(3): 629～633.
30. Cavanagh D.. Severe acute respiratory syndrome vaccine development; experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathology, 2003, 32 (6): 567～582.
31. Chen B.Y., Itakura C. Cytopathology of chick renal epithelial cells experimentally infected with avian infectious bronchitis virus, Avian Pathology 1996, 25(4):675～694.
32. Collins R.W.. Human MHC class I chain related (MIC) genes: their biological function and relevance to disease and transplantation. European Journal of Immunogenetics 2004, 31(3): 105～114.
33. Collission E.W, Pei J., Dzielawa J., Sao S.H.. Cytotoxic T lymphocytes are critical in control of infectious bronchitis virus in poutry. Developmental and Comparative Immunology 2000, 24(2-3): 187～200.
34. Collisson E.W., Parr R.L., Li W., Williams A.K.. An overview of the molecular characteristics of avian infectious bronchitis virus. Poultry Science Review 1992, 4(1): 41～55.
35. Corr M., Slanetz A.E., Boyd L.F., Jelonek M.T., Khilko S., al-Ramadi B.K., Kim Y.S., Maher S.E., Bothwell A.L., Margulies D.H.. T cell receptor-MHC class Ⅰ peptide interactions: affinity, kinetics, and specificity. Science 1994, 265 (5174): 946～949.
36． Crinion R.A.P.,Hofstad M.S..Pathogenicity of four serotypes of avian infectious bronchitis virus for the oviduct of young chickens of various ages.Avian Disease 1972,16(2) :351～363．
37． Di Fabio S.,Mbawuike I.N.,Kiyono H.,Fujihashi K..,Couch R.B.,McGhee J.R..Quantitation of human influenza virus-specific cytotoxic T lymphocytes:correlation of cytotoxicity and increased numbers of IFN-gamma producing CD8~+ T cells.International Immunology 1994,6(1) :11～19．
38． Doherty P.C.,Blanden R.B.,and Zinkernagel R.M..Specificity of virus-immune effector T cells for H-2K or H-2D compatible interactions:implications for H-antigen diversity.Transplant Review 1976,29:89～124．
39． Dohlsten M.,Sundstedt A.,Bjorklund M.,Hedlund G.,Kalland T..Super-antigen induced cytokines suppress growth of human colon-carcinoma cells.International Journal of Cancer 1993,54(3) :482～488．
40． Donahoe S.M.,Moretto W.J.,Samuel R.V.,Metzner K.J.,Marx P.A.,Hank T.,Connor R.I.,Nixon D.F..Direct measurement of CD8~+T cell responses in macaques infected with simian immunodeficiency virus.Virology 2000,272(2) :347～356．
41． Donahoe S.M.,Moretto W.J.,Samuel R.V.,Metzner K.J.,Marx P.A.,Hanke T.,Connor R.I.,Nixon D.F..Direct measurement of CD8+ T cell responses in macaques infected with simian immunodeficiency virus.Virology 2000,272(2) :347～356．
42． Dunbar P.R.,Ogg G.S.,Chen J.,Rust N.,van der Bruggen P.,Cerundolo V..Direct isolation,phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood.Current Biology 1998,8(7) :413～416
43． Echchakir H.,Dorothe G.,Vergnon I.,Menez J.,Chouaib S.,Mami-Chouaib F..Cytotoxic T lymphocytes directed against a tumor-specific mutated antigen display similar HLA tetramer binding but distinct functional avidity and tissue distribution.Proceeding of the National Academy of Sciences of the United States of America 2002,99(14) :9358～9363．
44． Egan M.A.,Pavlat W.A.,Tartaglia J.,Paoletti E.,Weinhold K.J.,Clements M.L.,Siliciano R.F..Induction of human immunodeficiency virus type 1(HIV-1) -specific cytolytic T lymphocyte responses in seronegative adults by a nonreplicating,host-range-restricted canaiypox vector(ALVAC)carrying the HIV-1 MN env gene.Journal of Infectious Disease 1995,171(6) :1623～1627．
45． Eliana D.B.C..Refolding of recombinant proteins.Current Opinion in Biotechnology 1998,9(2) :157～163．
46． Engstrand M.,Tournay C,Peyrat M.A.,Eriksson Britt-Marie,Wadstrom J.,Wirgart B.Z.,Romagne F.,Bonneville M.,Totterman T.H.,Korsgren O..Characterization of CMVpp65-Specific CD8~+ T Lymphocytes using MHC Tetramers in Kidney Transplant Patients and Health Participants.Transplantation 2000． 69(11) :2243～2250．
47． Fischer K.,Andreesen R.,Mackensen A..An improved flow cytometric assay for the determination of cytotoxic T lymphocyte activity.Journal of Inummological Methods 2002,259(1-2) :159～169．
48． Gallimore A.,Glithero A.,Godkin A.,Tissot A.C.,Plückthun A.,Elliott T.,Hengartner H.,Zinkernagel R..Induction and Exhaustion of Lymphocytic Choriomeningitis Virus-specific Cytotoxic T Lymphocytes Visualized Using Soluble Tetrameric Major Histocompatibility Complex Class I-Peptide Complexes.Journal of Experimental Medicine 1998,187(9) :1383-1393．
49． Garboczi D.N.,Hung D.T.,Wiley D.C..HLA-A2-peptide complexes:Refolding and crystallization of molecules expressed in scherichia coli and complexed with single antigenic peptides.Proceeding of the National Academy of Sciences of the United States of America 1992,89(8) :3429～3433
50． Garboczi D.N.,Utz U.,Ghosh P.,Seth A.,Kim J.,VanTienhoven E.A.E.,Biddison W.E.,Wiley D.C..Assembly,specific binding,and crystallization of a human TCR-alpha/beta with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2． The Journal of Immunology 1996,157(12) :5403～5410．
51． Garboczi,D.N.,Gosh P.,Utz U.,Fan Q.R.,Biddison W.E.,Wiley D.C..Structure of the complex between human T-cell receptor,viral peptide and HLAA2． Nature 1996,384(6605) :134～141．
52． Goldberg J.E.,Sherwood S.W.,Clayberger C..A novel method for measuring CTL and NK cell-mediated cytotoxicity using annexin V and two-color flow cytometry.Journal of Inummological Methods 1999,224(1-2) :1～9．
53． Griffioen M.,Borghi M.,Schrier P.I.,Osanto S..Detection and quantification of CD8+ T cells specific for HLA-A*0201-binding melanoma and viral peptides by the IFN-gamma-ELISPOT assay.International Journal of Cancer 2001,93(4) :549～55．
54． Haanen J.B.,Van Oijen M.G.,Tirion F.,Oomen L.C.,Kruisbeek A.M.,Vyth-Dreese F.A.,Schumacher T.N..In situ detection of virus-and tumor-specific T-cell immunity.Nature Medicine 2000,6(9) :1056～1060．
55． Herr W.,Schneider J.,Lohse A.W.,Meyer zum Buschenfelde K.H.,Wolfel T..Detection and quantification of blood derived CD8~+ T lymphocytes secreting tumor necrosis factor alphain response to HLA-A2． 1 binding melanoma and viral peptide antigens.Journal of Inummological Methods 1996,191(2) :131～142．
56． Hofstad M.S..Avian infectious bronchitis.In:Calnek B.W.,Barnes H.J.,Beard C.W.,Reid W.M.,Yoder H.W.,editors.Diseases of poultry.Ames,IA:Iowa State University Press,1984． p.429～243[8~(th) ed.].
57． Hogquist K.A.,Jameson S.C.,Heath W.R.,Howard J.L.,Bevan M.J.,Carbone F.R..T cell receptor antagonist peptides induce positive selection.Cell 1994． 76(1) :17～27．
58． Hugues S.,Malherbe L.,Filippi,Glaichenhaus N..Generation and use of alternative multimers of peptide pMHC complexes.Journal of Immunological Methods 2002,268(1) :83～92
59． Ignjatovic J.,Galli L..The S1 glycoprotein but not the N or M proteins of avian infectious bronchitis virus induces protection in vaccinated chickens.Archives of Virology 1994,138(1-2) :117～134．
60． Ikemura,T.Codon usage and tRNA content in unicellular and multicellular organisms.Molecular Biology and Evolution.1985,2(1) :13～34．
61． Jager E.,Hohn H.,Necker A.,Forster R.,Karbach J.,Freitag K.,Neukirch C.,Castelli C,Salter R.D.,Knuth A.,Maeurer M.J.Peptide-specific CD8~+ T cell evolution vivo:response to peptide vaccination with Melan-A/MART-1． International Journal of Cancer 2002,98(3) :376～388。
62． Jauknecht R.,Martynoff G.,Lou J.,Hipskind R.A.,Nordheim A.,Stunnenberg H.G..Rapid and efficient purification of native histidine tagged protein expressed by recombinant vaccinia virus.Proceeding of the National Academy of Sciences of the United States of America 1991,88(20) :8972～8976．
63． Jung T.,Schauer U.,Heusser C.,Neumann C.,Rieger C..Detecion of intracellular cytokines by flow cytometry.Journal of Immunological Methods 1993,159(1-2) :197～207．
64． Kalergis A.M.,Goyarts E.C.,Palmieri E.,Honda S.,Zhang W.,Nathenson S.G..A simplified procedure for the preparation of MHC/peptide tetramers:chemical biotinylation of an unpaired cysteine engineered at C-terminus of MHC-I.Journal of Immunological Methods 2000,234(1-2) :61～67．
65． Kaufman J.,Andersen R.,Avila D.,Engberg J.,Lambris J.,Salomonsen J.,Welinder K,Skjodt K..Different features of the MHC class I heterodimer have evolved at different rates.Chicken B-F and beta 2-microglobulin sequences reveal invariant surface residues.Journal of Immunology.1992,148(5) :1532～1546．
66． Kaufman J.,Milne S.,Gobel T.W.,Walker B.A.,Jacob J.P.,Auffray C,Zoorob R.,Beck S..The chicken B locus is a minimal essential major histocompatibility complex.Nature 1999,401(6756) :923～925．
67． Koch G,Hartog L.,Kant A.,van Roozelaar D.J..Antigenic domains on the peplomer protein of avian infectious bronchitis virus:correlation with biological functions.Journal of General Virology 1990,71(9) :1929～1935．
68． Kotani T.,Wada S.,Tsukamoto Y.,Kuwamura M.,Yamate J.,Sakuma S..Kinetics of lymphocytic subsets in chicken tracheal lesions Infected wit h infectious bronchitis virus.Veterinary Medicine Science,2000,62(4) :379～401．
69． Kozlowski S,Takeshita T,Boehncke WH,Takahashi H,Boyd LF,Germain RN,Berzofsky JA,Margulies DH.Excess β2-microglobulin promoting functional peptide association with purified soluble class I MHC molecules.Nature,1991,349(6304) :74～77．
70． Laitinen O.H.,Marttila A.T.,Airenne K.J.,Kulik T.,Livnah O.,Bayer E.A.,Wilchek M.,Kulomaa M.S..Biotin induces tetramerization of a recombinant monomeric avidin.The Journal of Biological Chemistry 2001,276(11) :8219～8224．
71． Lechnera F.,Wongc D.K.H.,Rod Dunbarb R,Chapmana R.,Chungd R.T.,Dohrenwendc R,Robbinsc G,PhillipsaR.,Klenermana R,Walkerc B.D..Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus.Journal of Experimental Medicine 2000,191(9) :1499～1512．
72． Lecoeur H.,Fevrier M.,Garcia S.,Riviere Y.,Gougeon M.L..A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity.Journal of Inummological Methods 2001,253(1-2) :177～187．
73． Lenstra J.A.,Kusters J.G.,Koch G.,van der Zeijst B.A.M.Antigenicity of the peplomer protein of infectious bronchitis virus.Molecular Immunology 1989,26(1) :7～15．
74． Lin Y.L.,and Askonas B.A..Biological properties of an influenza A virus-specific killer T-cell clone.Journal of Experimental Medicine 1981,154(2) :225～234．
75． Liu C.P.,Jiang K.,Wu C.H.,Lee W.H.,Lin W.J..Detection of glutamic acid decarboxylase-activated T cells with I-Ag7 tetramers.Proceeding of National Academy of Science of the United States of America 2000,97(26) :14596～14601．
76． Liu D.X.,lnglis S.C..Association of the infectious bronchitis virus 3c protein with the virion envelope.Virology 1991,185(2) :911～917．
77． Lomniczi B.Biological properties of avian coronavirus RNA.Journal of General Virology 1977,36(3) :531～533．
78． Lucio B.,Fabricant J..Tissue tropism of three cloacal isolates and Massachusetts strain of infectious bronchitis virus.Avian Disease 1990,34(4) :865～870．
79． Maier B.,Buhring H.J.,Simon M.,Eichmann K.,Melchers I..Limiting dilution analysis of proliferating and helper T cells in the in vivo immune response to K.LH:derepression of helper T cells at moderately increased frequencies.Journal of Molecular and Cellular Immunology 1986,2(5) :293～305．
80． Maile R.,Wang B.,Schooler W.,Meyer A.,Collins E.J.,Frelinger J.A..Antigen-specific modulation of an immune response by in vivo administration of soluble MHC class Ⅰ tetramers.Journal of Immunology 2001,167(7) :3708～3714．
81． Mallone R.,Nepom GT..MHC Class Ⅱ tetramers and the pursuit of antigen-specific T cells:define,deviate,and delete.Journal Clinical Immunology,2004,110(3) :232～242．
82． Mamalaki C,Elliott J.,Norton T.,Yannoutsos N.,Townsend A.R.,Chandler P.,Simpson E.,Kioussis D..Positive and negative selection in transgenic mice expressing a T-cell receptor specific for influenza nucleoprotein and endogenous superantigen.Developmental Immunology 1993,3(3) :159～174．
83． Matsui K.,Boniface J.J.,Reay P.A.,Schild H.,Fazekas de St Groth B.,Davis M.M..Low affinity interaction of peptide-MHC complexes with T cell receptors.Science 1991,254(5039) :1788～1791．
84． McMichael A.J.,Kelleher A..The arrival of HLA class Ⅱ tetramers.Journal of Clinical Investigation 1999,104(12) :1669-1670．
85． McMichael,A.,O'Callaghan C..A new look at T cells.The Journal of Experimental Medicine 1998,187(9) :1367～1371．
86． McNeal M.M.,Barone K.S.,Rae M.N.,and Ward R.L..Effector functions of antibody and CD81 cells in resolution of rotavirus infection and protection against reinfection.Virology 1995,214(11) :387～397．
87． Mealey R.H.,Sharif A.,Ellis S.A.,Littke M.H.,Leib S.R.and McGuire T.C.Early detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes.Virology 2005,339(1) :110～126．
88． Meidenbauer N.,Hoffmann T.K.,Donnenberg A.D..Direct visualization of antigen-specific T cells using peptide-MHC-class Ⅰ tetrameric complexes.Methods 2003,31(2) :160～171．
89． Michaelsson J.,Achour A.,Salcedo M.,Kase-Sjostrom A.,Sundback J.,Harris R.A.,Karre K..Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class Ⅰ tetramers.European Journal of Immunology 2000,30(1) :300～307．
90． Miller M.M.,Bacon L.D.,Hala K.,Hunt H.D.,Ewald S.J.,Kaufman J.,Zoorob R.,Briles W.E..Nomenclature for the chicken major histocompatibility(B and Y)complex.Immunogenetics 2004,56(4) :261～79．
91． Miller M.M.,Goto R.,Bernot A.,Zoorob R.,Auffray C,Bumstead N.,Briles W.E..Two MHC class Ⅰ and two MHC class Ⅱ genes map to the chicken Rfp-Y system outside the B complex.Proceeding National Acad Sciences 1994,91(10) :4397～4401．
92． Mondal S.P.,Naqi S.A..Maternal antibody to Infectious bronchitis virus:its role in protection against infection and development of active immunity to vaccine.Veterinary,2001,79(1-2) :31～40．
93． Murali-Krishna K.,Altman J.D.,Suresh M.,Sourdive D.J.,Zajac A.J.,Miller J.D.Slansky J.,Ahmed R..Counting antigen-specific CD8 T cells:a reevaluation of bystander activation during viral infection.Immunity 1998,8(2) :177～187．
94． Niesters H.G.M.,Bleumink-Pluym N.M.,Osterhaus A.D,Horzinek M.C.,van der Zeijst B.A..Epitopes on the peplomer protein of infectious bronchitis virus strain M41 as defined by monoclonal antibodies.Virology 1987,161(2) :511～519．
95． Nociari M.M.,Shalev A.,Benias P.,Russo C..A novel one-step,highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity.Journal of Inummological Methods 1998,213(2) :157～167．
96． Novak E.J.,Liu A.W.,Gebe J.A.,Falk B.A.,Nepom G.T.,Koelle D.M.,Kwok W.W..Tetramer-guided epitope mapping:rapid identification and characterization of immunodominant CD4+T cell epitopes from complex antigens.Journal of Immunology 2001,166(11) :6665～6670．
97． Oleksiewicz M.B.,Kristensen B..Ladekj?r-Mikkelsen A.S.,Nielsen J..Development of a rapid in vitro protein refolding assay which discriminates between peptide-bound and peptide-free forms of recombinant porcine major histocompatibility class Ⅰ complex(SLA-I).Veterinary Immunology and Immunopathology 2002,86(1-2) :55～77．
98． Otten G.R.,Bikoff E.,Ribaudo R.K.,Kozlowski S.,Margulies D.H.,Germain R.N..Peptide and β2-microglobulin regulation of cell surface MHC class Ⅰ conformation and expression.Journal of Immunology 1992,148(12) :3723～3732．
99． Owen J.A.,Allouche M.,Doherty PC..Limiting dilution analysis of the specificity of influenza-immune cytotoxic T cells.Cell Immunology 1982,67(1) :49～59．
100． Pala P.,Hussell T.,Openshaw P.J.M..Flow cytometric measurement of intracellular cytokine.Journal of Inummological Methods 2000,243(1-2) :107～124
101． Parker K.C.,Silver M.L.,Wiley D.C..An HLA-A2/Pbeta2-microglobulin/peptide complex assembled from subunits expressed separately in Escherichia coli.Molecular Immunology 1992,29(3) :371～378．
102． Piao W.,Song X.,Liu M.,He Y.,Zhang H.,Xu W.,Li Z.,Zhang H.,Ling S.,Wang G..Cloning,expression,and purification of HLA-A2-BSP and β2m in Escherichia coli.Protein Expression and Purification 2004,35(2) :210～217．
103． Prussin C.,Metcalfe DD.Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies.Journal of Inummological Methods 1995,188(1) :117～128．
104． Rehermann B.,Chang K.M.,McHutchison J.,Kokka R.,Houghton M.,Rice C.M.,Chisari F.V..Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients.Journal of Virology 1996,70(10) :7092～7102．
105． Rehermann B.,Chang K.M.,McHutchison J.,Kokka R.,Houghton M.,Rice CM.,Chisari F.V..Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.Journal of Clinical Investigation 1996,98(6) :1432～1440．
106． Reignat S.,Webster G.J.,Brown D.,Ogg G.S.,King A.,Seneviratne S.L.,Dusheiko G.,Williams R.,Maini M.K.,Bertoletti A..Escaping high viral load exhaustion:CD8 cells with altered tetramer binding in chronic hepatitis B virus infection.Journal of Experimental Medicine 2002,195(9) :1089～1101．
107． Reusser,P.,Riddell S.R.,Meyers J.D.,and Greenberg P.D..Cytotoxic T lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation:pattern of recovery and correlation with cytomegalovirus infection and disease.Blood 1991,78(5) :1373～1380．
108． Robert B.,Guillaume P.,Luescher I.,Romero P.,Mach J.P..Antibody-conjugated MHC class Ⅰ tetramers can target tumor cells for specific lysis by T lymphocytes.European Journal of Immunology 2000,30(11) :3165～3170．
109． Roden M.M.,Lee K.H.,Panelli M.C.,Marincola F.M..A novel cytolysis assay using Fluorescent labeling and quantitative fluorescent scanning technology.Journal of Inummological Methods 1999,226(1-2) :29～41．
110． Schagger H.,Jagow G.V..Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.Analytical Biochemistry 1987,166(2) :368～379．
111． Schatz J..Use of peptide libraries to map the substrate of a peptide modifying enzyme:A 13 residue consensus peptide specifies biotinylation in Escherichia coli.Biotechnology 1993,11:1138～1143．
112． Schatz,P.J.Use of peptide libraries to map the substrate specificity of apeptide modifying enzyme:a 13 residue consensus peptide specifies biotinylation in Escherichia coli.Biotechnology 1993,11(10) :1138～1143．
113． Scheibenbogen C,Lee K.H.,Mayer S.,Stevanovic S.,Moebius U.,Herr W.,Rammensee H.G.,Keilholz U..A sensitive ELISPOT assay for detection of CD8+ T lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients.Clinical Cancer Research 1997,3(2) :221～226．
114． Scheibenbogen C,Lee K.H.,Stevanovic S.,Witzens M.,Willhauck M.,Waldmann V.,Naeher H.,Rammensee H.G.,Keilholz U..Analysis of the T cell response to tumor and viral peptide antigens by an IFN gamma-ELISPOT assay.International Journal of Cancer 1997,71(6) :932～936．
115． Scheibenbogen C.,Romero P.,Rivoltini L.,Herr W.,Schmittel A.,Cerottini J.C.,Woelfel T.,Eggermont A.M.,Keilholz U..Quantitation of antigen-reactive T cells in peripheral blood by IFN-gamma-ELISPOT assay and chromium-release assay:a four-centre comparative trial.Journal of Immunological Methods 2000,244(1-2) :81～89．
116． Schneider J.,Gilbert S.C.,Blanchard T.J.,Hanke T.,Robson K.J.,Hannan CM.,Becker M.,Sinden R.,Smith G.L.,Hill A.V..Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.Nature Medicine 1998,4(4) :397～402．
117． Schochetman G.,Stevens R.H.,Simpson R.W..Presence of infectious polyadenylated RNA in the coronavirus avian bronchitis virus.Virology 1977,77(2) :772～782．
118． Seah J.N.,Yu L.and Kwang J..Localization of linear B cell epitopes on infectious bronchitis virus nucleocapsid protein.Veterinary Microbiology 2000,75(1) :11～16．
119． Seo H.S.,Collisson E.W..Specific cytotoxic T lymphocytes are involved in in vivo clearance of infectious bronchitis virus.Journal of Virology 1997,71(7) :5173～5177．
120． Seo U.S.,Wang L.,Smith R..The carboxy-terminal 120-residue polypeptide of infectious bronchitis virus from nucleocapsid induces cytotoxic T lymphocytes and protects chickens from acute infection.Journal of Virology 1997,71(10) :7889～7894．
121． Seo,S.H.,Pei J.,Briles W.E.,Dzielawa J.,Collisson E.W..Adaptive transfer of infectious bronchitis virus primed αβ T cells bearing CD8 antigen protects chicks from acute infection.Virology 2000,269(1) :183～189．
122． Serbina N.,Pamer E.G.Quantitative studies of CD8+ T-cell responses during microbial infection.Current Opinion in Immunology 2003,15(4) :436～442．
123． Sha W.C.,Nelson C.A.,Newberry R.D.,Kranz D.M.,Russell J.H.,Loh D.Y..Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice.Nature 1988,335(6187) :271～274．
124． Shalk AF,Hawn MC.An apparently new respiratory disease of baby chicks.Journal of American Veterinary Medical Association 1931,78:413～422．
125． Sharrock C.E.,Kaminski E.,Man S..Limiting dilution analysis of human T cells:a useful clinical tool.Immunology Today 1990,11(8) :281～286．
126． Shields M.J.,Assefi N.,Hodgson W.,Kim E.J.,Ribaudo R.K..Characterization of the interactions between MHC class I subunits:a systematic approach for the engineering of higher affinity variants of β2-microglobulin.Journal of Immunology 1998a,160(5) :2297～2307．
127． Shields M.J.,Kubota R.,Hodgson W.,Jacobson S.,Biddison W.E.,Ribaudo R.K..The effect of human β2-microglobulin on major histocompatibility complex I peptide loading and the engineering of a high affinity variant.The Journal of Biological Chemistry 1998b,273(43) :28010～28018．
128． Skinner P.J.,Daniels M.A.,Schmidt C.S.,Jameson S.C.,Haase A.T..Cutting edge:in situ tetramer staining of antigen specific T cells in tissues.Journal of Immunology 2000,165(2) :613～617．
129． Tarbell K.V.,Lee M.,Ranheim E.,Chao C.C.,Sanna M.,Kim S.K.,Dickie P.,Teyton L.,Davis M.,McDevitt H..CD4(+)T cells from glutamic acid decarboxylase(GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer.J Exp Med,2002,196(4) :481～492．
130． Tashiro M,Fujii Y.,Nakamura K.,and Homma M..Cell-mediated immunity induced in mice after vaccination with a protease activation mutant,TR-2,of Sendai virus.Journal of Virology 1988,62(7) :2490～2497．
131． Taswell C..Limiting dilution assays for the determination of immunocompetent cell frequencies I.Data analysis.Journal of Immunology 1981,126(4) :1614～1619．
132． Thacker E.L.,Fulton J.E.,and Hunt H.D..In vitro analysis of a primary,major histocompatibility complex(MHC)-restricted,cytotoxic Tlymphocyte response to avian leukosis virus(ALV),using target cells expressing MHC class Ⅰ cDNA inserted into a recombinant ALV vector.Journal of Virology 1995,69(10) :6439-6444．
133． Tobias J.W.,Shader T.E.,Rocap G.,Varchavsky A..The N end rule in bacteria.Science 1991,254(5036) :1374～1377．
134． Toes R.E.,Offringa R.,Blom R.J.,Melief C.J.,Kast W.M..Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.Proceeding of National Academy of Science of the United States of America 1996,93(15) :7855～7860．
135． Tora H.,Espinoza C,Ponce V.,Rojas V.,Morales M.A.,Kaleta E.F..Infectious bronchitis effect of viral dose and routes on specific lacrimal and serum antibody response in chickens.Avian Disease,1997,4(2) :379～387．
136． Townsend A.,and Bodmer H..Antigen recognition by class I-restricted T lymphocytes.Annually Review of Immunology 1989,7(4) :601-624．
137． Tsang K.Y.,Zaremba S.,Nieroda C.A.,Zhu M.Z.,Hamilton J.M.,Schlom J..Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine.Journal of the National Cancer Institute 1995,87(13) :982～990．
138． Walter J.B.,Garboczi D.N.,Fan Q.R.,Zhou X.,Walker B.D.,Eisen H.N..A mutant human β2-microglobulin can be used to generate diverse multimeric class I peptide complexes as specific probes for T cell receptors.Journal of Immunological Methods 1998,214(1-2) :41～50．
139． Wang B.,Chen H.,Cao X.,Jiang X.,Zhang M.,Wan T.,Li N.,Zhou X.,Wu Y.,Yang F.,Yu Y.,Wang X.,Yang R..Identification of an HLA-A*0201-restricted CD8+T-cell epitope SSp-1 of SARS-CoV spike protein.Blood 2004,104(1) :200～206．
140. Weber S., Traunecker A., Oliveri F., Gerhard W., Karjalainen K.. Specific low-affinity recognition of major histocompatibility complex plus peptide by soluble T-cell receptor. Nature 1992, 356 (6372): 793～796.
141. Wilson J.D., Ogg G.S., Allen R.L., Chao C.C., Sanna M., Kim S.K., Dickie P., Teyton L., Davis M., McDevitt H.. Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection. AIDS, 2000(3), 14: 225～233.
142. Wolfl M., SchalkS., Hellmich M., Huster K.M., BuschD.H., Berthold F. Quantitation of MHC tetramer-positive cells from whole blood: evaluation of a single-platform, six-parameter flow cytometric method. Cytometry 2004, 57(2): 120～130.
143. Yang J., Jaramillo A., Shi R., Kwok W.W., Mohanakumar T.. In vivo biotinylation of the major histocompatibility complex (MHC) class Ⅱ/peptide complex by coexpression of BirA enzyme for the generation of MHC class Ⅱ/tetramers. Human Immunology 2004, 65(7): 692～699.
144. Yewdell J.W., Bennink J.R.. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes. Science 1989, 244(4908): 1072～1075.
145. Yu L., Liu W., Schnizlein W.M., Frippathy D.N., Kwang J.. Study of protection by recombinant fowl poxvirus expressing C-teminal nucleoeapsid protein of infectious bronchitis virus against challenge. Avian Disease 2001, 45(2): 340～348.
146. Yuriko S., Hiroeki S., Tomohide T., Masako K., Yoshihiko H., Yuki N., Satoshi K., Hideyuki I., Toshihiko T., Shingo I., Yasuaki T., Takuro W., Toshihiko Y., Masashi G., Hideo T., Noriyuki S.. Improved generation of HLA class Ⅰ/peptide tetramers. Journal of Immunological Methods 2002, 271(1-2): 177～184.